State and self investments in health

Eleonora Fichera, Matt Sutton

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this paper we consider how State investments can crowd out or reinforce self-investments in health using a theoretical model of insurance and protection. We apply this model to the smoking cessation decision made by individuals diagnosed with a cardiovascular disease using data from the 1998, 2003 and 2006 waves of the Health Survey of England. Prescription of lipid-lowering drugs, which increased substantially over this period, is used as the measure of State investment. Using bivariate and trivariate probit models, we allow for the endogeneity of the doctor's decision to prescribe and offer smoking cessation advice. We find that unobservable characteristics affecting the prescription of drugs are positively correlated with those affecting smoking advice and negatively correlated with those affecting the propensity to quit. Our results indicate that prescription of lipid-lowering drugs to individuals with cardiovascular disease increases the probability of smoking cessation by 20–28 percentage points.
Original languageEnglish
Pages (from-to)1164-1173
JournalJournal of Health Economics
Volume30
Issue number6
Early online date17 Sep 2011
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Smoking Cessation
Prescriptions
Health
Cardiovascular Diseases
Lipids
Prescription Drugs
Health Surveys
Insurance
England
Pharmaceutical Preparations
Theoretical Models
Smoking

Cite this

State and self investments in health. / Fichera, Eleonora; Sutton, Matt .

In: Journal of Health Economics, Vol. 30, No. 6, 12.2011, p. 1164-1173.

Research output: Contribution to journalArticle

Fichera, Eleonora ; Sutton, Matt . / State and self investments in health. In: Journal of Health Economics. 2011 ; Vol. 30, No. 6. pp. 1164-1173.
@article{f9f61202bcbc41f3bfe11fc5872d6409,
title = "State and self investments in health",
abstract = "In this paper we consider how State investments can crowd out or reinforce self-investments in health using a theoretical model of insurance and protection. We apply this model to the smoking cessation decision made by individuals diagnosed with a cardiovascular disease using data from the 1998, 2003 and 2006 waves of the Health Survey of England. Prescription of lipid-lowering drugs, which increased substantially over this period, is used as the measure of State investment. Using bivariate and trivariate probit models, we allow for the endogeneity of the doctor's decision to prescribe and offer smoking cessation advice. We find that unobservable characteristics affecting the prescription of drugs are positively correlated with those affecting smoking advice and negatively correlated with those affecting the propensity to quit. Our results indicate that prescription of lipid-lowering drugs to individuals with cardiovascular disease increases the probability of smoking cessation by 20–28 percentage points.",
author = "Eleonora Fichera and Matt Sutton",
year = "2011",
month = "12",
doi = "10.1016/j.jhealeco.2011.09.002",
language = "English",
volume = "30",
pages = "1164--1173",
journal = "Journal of Health Economics",
issn = "0167-6296",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - State and self investments in health

AU - Fichera, Eleonora

AU - Sutton, Matt

PY - 2011/12

Y1 - 2011/12

N2 - In this paper we consider how State investments can crowd out or reinforce self-investments in health using a theoretical model of insurance and protection. We apply this model to the smoking cessation decision made by individuals diagnosed with a cardiovascular disease using data from the 1998, 2003 and 2006 waves of the Health Survey of England. Prescription of lipid-lowering drugs, which increased substantially over this period, is used as the measure of State investment. Using bivariate and trivariate probit models, we allow for the endogeneity of the doctor's decision to prescribe and offer smoking cessation advice. We find that unobservable characteristics affecting the prescription of drugs are positively correlated with those affecting smoking advice and negatively correlated with those affecting the propensity to quit. Our results indicate that prescription of lipid-lowering drugs to individuals with cardiovascular disease increases the probability of smoking cessation by 20–28 percentage points.

AB - In this paper we consider how State investments can crowd out or reinforce self-investments in health using a theoretical model of insurance and protection. We apply this model to the smoking cessation decision made by individuals diagnosed with a cardiovascular disease using data from the 1998, 2003 and 2006 waves of the Health Survey of England. Prescription of lipid-lowering drugs, which increased substantially over this period, is used as the measure of State investment. Using bivariate and trivariate probit models, we allow for the endogeneity of the doctor's decision to prescribe and offer smoking cessation advice. We find that unobservable characteristics affecting the prescription of drugs are positively correlated with those affecting smoking advice and negatively correlated with those affecting the propensity to quit. Our results indicate that prescription of lipid-lowering drugs to individuals with cardiovascular disease increases the probability of smoking cessation by 20–28 percentage points.

U2 - 10.1016/j.jhealeco.2011.09.002

DO - 10.1016/j.jhealeco.2011.09.002

M3 - Article

VL - 30

SP - 1164

EP - 1173

JO - Journal of Health Economics

JF - Journal of Health Economics

SN - 0167-6296

IS - 6

ER -